Cargando…
Immunotherapy of Multiple Myeloma: Current Status as Prologue to the Future
The landscape of therapeutic measures to treat multiple myeloma has undergone a seismic shift since the dawn of the current century. This has been driven largely by the introduction of new classes of small molecules, such as proteasome blockers (e.g., bortezomib) and immunomodulators (e.g., lenalido...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649824/ https://www.ncbi.nlm.nih.gov/pubmed/37958658 http://dx.doi.org/10.3390/ijms242115674 |